NCT07178834

Brief Summary

The goal of this clinical trial is to assessing safety and the occurrence of adverse effects during tele-rehabilitation (TRHB) in people with multiple sclerosis with an EDSS score of 6.5 or lower. The main questions it aims to answer are:

  • Intervention using TRHB is considered safe and without adverse effects.
  • Intervention using TRHB has a high degree of self-adherence, an impact on physical activity levels and self-efficacy in exercise, and a positive effect on quality of life, mood, and perception of fatigue. Researchers will compare the tele-rehabilitation with rehabilitation based solely on physical activity recommendations. Participants will complete three weekly online rehabilitation sessions and must attend three follow-up visits.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
75

participants targeted

Target at P50-P75 for not_applicable multiple-sclerosis

Timeline
Completed

Started Feb 2025

Shorter than P25 for not_applicable multiple-sclerosis

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 10, 2025

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

July 4, 2025

Completed
3 months until next milestone

First Posted

Study publicly available on registry

September 17, 2025

Completed
13 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2025

Completed
Last Updated

September 17, 2025

Status Verified

September 1, 2025

Enrollment Period

8 months

First QC Date

July 4, 2025

Last Update Submit

September 10, 2025

Conditions

Keywords

TelerehabilitationRehabilitatitonPatient-Reported Outcome Measures

Outcome Measures

Primary Outcomes (1)

  • Adverse events

    Adverse events such as falls, pain, fatigue, and others that may occur.

    From enrollment to the end of treatment in week 8

Secondary Outcomes (4)

  • Multiple Sclerosis Quality of Life 54

    (T1) baseline, (T2) after the 8 week, (T3) at 16 week.

  • 10 meters walking test

    (T1) baseline, (T2) after the 8 week, (T3) at 16 week.

  • 6 minute walking test

    (T1) baseline, (T2) after the 8 week, (T3) at 16 week.

  • Berg Balance Scale

    (T1) baseline, (T2) after the 8 week, (T3) at 16 week.

Study Arms (2)

Intervention group: tele-rehabilitation

EXPERIMENTAL

This group will do online rehabilitation three times a week. Every two weeks, an assessment will be made to determine whether to increase the intensity of the exercise

Behavioral: Telerehab

Control group: physical activity recommendations

NO INTERVENTION

This group will only have access to basic recommendations for physical activity.

Interventions

TelerehabBEHAVIORAL

Adverse events are observed during online rehabilitation with computer vision technology in patients with MS.

Also known as: Telerehabilitation, Intervention group
Intervention group: tele-rehabilitation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients diagnosed with multiple sclerosis confirmed using the 2017 McDonald criteria.
  • Patients who have the technological means to conduct online sessions and the autonomy to do so.
  • Patients with cognitive capacity that allows them to sign the informed consent form.
  • Patients with an internet connection and a device compatible with the Rehub tele-rehabilitation platform (desktop computer, laptop, or tablet).
  • EDSS level less than or equal to 6.5.

You may not qualify if:

  • Participants who are currently undergoing RHB at a center.
  • Participants who have undergone RHB during the two months prior to the start of the program.
  • Patients with physical or mental comorbidities that may limit their participation in the rehabilitation program.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Multiple Sclerosis Center of Catalonia

Barcelona, 08035, Spain

Location

Related Publications (5)

  • Yau T, McIntyre M, Chan J, Bhogal D, Andreoli A, Bayley M, Leochico CFD, Kua A, Guo M, Munce S. Adverse events associated with the delivery of telerehabilitation: A scoping review protocol. PLoS One. 2024 Feb 21;19(2):e0297908. doi: 10.1371/journal.pone.0297908. eCollection 2024.

  • Doherty F, Lynch P, Powell P, Monaghan K. Feasibility and effectiveness of telerehabilitation on mobility and balance function in multiple sclerosis: A systematic review and meta-analysis. J Neurol Sci. 2024 Nov 15;466:123214. doi: 10.1016/j.jns.2024.123214. Epub 2024 Sep 4.

  • Xiang XM, Bernard J. Telehealth in Multiple Sclerosis Clinical Care and Research. Curr Neurol Neurosci Rep. 2021 Feb 28;21(4):14. doi: 10.1007/s11910-021-01103-4.

  • Harkey LC, Jung SM, Newton ER, Patterson A. Satisfacció del pacient amb la telesalud en entorns rurals: una revisió sistemàtica. Revista Internacional de Telerehabilitació. 2020;12(2):53-64. doi: 10.5195/ijt.2020.6303

    RESULT
  • Fjeldstad-Pardo C, Thiessen A, Pardo G. Telerehabilitation in Multiple Sclerosis: Results of a Randomized Feasibility and Efficacy Pilot Study. Int J Telerehabil. 2018 Dec 11;10(2):55-64. doi: 10.5195/ijt.2018.6256. eCollection 2018 Fall.

MeSH Terms

Conditions

Multiple Sclerosis

Interventions

Telerehabilitation

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System Diseases

Intervention Hierarchy (Ancestors)

RehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and ServicesTelemedicineDelivery of Health CarePatient Care ManagementHealth Services Administration

Study Officials

  • Edwin R Meza Murillo, Dr

    Multiple Sclerosis Center of Catalonia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
DR

Study Record Dates

First Submitted

July 4, 2025

First Posted

September 17, 2025

Study Start

February 10, 2025

Primary Completion

September 30, 2025

Study Completion

September 30, 2025

Last Updated

September 17, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations